Reuters Health – Stereotactic body radiation therapy halts lung tumor progression in frail inoperable patients (Nov. 4, 2009)
Stereotactic body radiation therapy (SBRT) can effectively treat very early stage 1 non-small cell lung cancer in patients who are too frail to undergo surgery, according to phase II trial results presented at the American Society for Radiation Oncology annual meeting (ASTRO 2009). SBRT involves just 3 outpatient sessions that last one hour each. Dr. Robert Timmerman comments.
Read More

Dallas Morning News – Dallas area sees significant growth
in clinical trials (Nov. 4, 2009)
Testing a new drug on patients used to be done at universities, which could count on hundreds of millions of dollars a year to conduct the trials. But as pharmaceutical companies look to cut costs and get drugs to market quicker, outsourcing to other companies is an increasingly popular option. There are 877 clinical trials in Dallas looking for participants, according to clinicaltrials.gov, a Web site maintained through the U.S. National Institutes of Health. But 70 percent of clinical trials are conducted in the private sector with individual companies overseeing drug testing, said Dr. Perrie Adams, associate dean of research administration at UT Southwestern. Read More

Dallas Morning News – New treatments and technologies ease burden on diabetes patients (Nov. 4, 2009)
In recent years, new drugs that can help a diabetic's pancreas work optimally have given doctors new options in controlling the disease. But they do have side effects, some dangerous, that can prevent their use. Patients with heart disease or shortness of breath, for example, can't usually tolerate these drugs. Dr. Ildiko Lingvay comments. Read More